NCT06747923 - SB17170 Phase 2 Trial in IPF Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 27, 2025

Primary Completion Date

April 7, 2026

Study Completion Date

October 31, 2026

Conditions

IPFIdiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)

Interventions

DRUG

SB17170

Taking SB17170 orally once a day

DRUG

Placebo

Taking Placebo orally once a day

Trial Locations (5)

RECRUITING

Myong Ji Hospital, Goyang

RECRUITING

Chung-Ang University Gwangmyeong Hospital, Gwangmyeong

NOT_YET_RECRUITING

Seoul Asan Hospital, Seoul

NOT_YET_RECRUITING

The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul

NOT_YET_RECRUITING

Ajou University Hospital, Suwon